New $58 Million Funding to Develop Potential Once-Daily Pill for Rare Bleeding Disorder HHT
RougeTx, a biotechnology company, has raised $58 million in its first major funding round to develop a new oral treatment […]
RougeTx, a biotechnology company, has raised $58 million in its first major funding round to develop a new oral treatment […]
This week brought important updates in the world of pharmaceuticals and healthcare. Here’s what you need to know, explained in
Bayer, a global pharmaceutical company, is spending $2.2 billion to build a new, highly automated manufacturing site in New Albany,
A major breakthrough in brain research has earned three scientists the 2026 Nobel Prize in Physiology or Medicine. Their work
Mothers whose babies became very ill with sepsis or meningitis caused by a bacteria called group B streptococcus (GBS) are
A new treatment called Tryngolza (olezarsen) has been recommended by NICE (National Institute for Health and Care Excellence) for adults
A partnership between Samsung Bioepis and Teva Pharmaceuticals has grown to include up to six new potential biosimilar medicines. This
Boehringer Ingelheim, a pharmaceutical company, has shared exciting new results from a late-stage study (called the SYNCHRONIZE-2 trial) of a
A new immunotherapy treatment has been approved by the U.S. Food and Drug Administration (FDA) to help reduce the risk
AbbVie has received approval from the European Commission for their medication Rinvoq (upadacitinib) to treat children aged two years and